Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
MYL-1401O is a biosimilar of trastuzumab that demonstrates comparable safety and efficacy in ERBB2 (HER2)-positive breast cancer patients (J Clin Oncol 34, 2016 (suppl; abstr LBA503)).
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|MYL-1401O + Paclitaxel||MYL-1401O Paclitaxel||1||0|